Publications by authors named "Brian D Juran"

Claim this Profile
E
Epigenetic disease markers in primary sclerosing cholangitis and primary biliary cholangitis-methylomics of cholestatic liver disease.
Brian D Juran, Bryan M McCauley, Elizabeth J Atkinson, Erik M Schlicht, Jackie K Bianchi

Hepatol Commun· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to: "An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs" [J Hepatol 75 (2021) 572-581].
Heather J Cordell, James J Fryett, Kazuko Ueno, Rebecca Darlay, Yoshihiro Aiba, Brian D Juran

J Hepatol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting cholangiocarcinoma in primary sclerosing cholangitis: using artificial intelligence, clinical and laboratory data.
Chang Hu, Ravishankar K Iyer, Brian D Juran, Bryan M McCauley, Elizabeth J Atkinson

BMC Gastroenterol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Environmental chemicals and endogenous metabolites in bile of USA and Norway patients with primary sclerosing cholangitis.
Caroline W Grant, Brian D Juran, Ahmad H Ali, Erik M Schlicht, Jackie K Bianchi

Exposome· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-Resolution Exposomics and Metabolomics Reveals Specific Associations in Cholestatic Liver Diseases.
Douglas I Walker, Brian D Juran, Angela C Cheung, Erik M Schlicht, Yongliang Liang

Hepatol Commun· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA methylation profile of liver tissue in end-stage cholestatic liver disease.
Angela C Cheung, Brian D Juran, Erik M Schlicht, Bryan M McCauley, Elizabeth J Atkinson

Epigenomics· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induced Pluripotent Stem Cells From Subjects With Primary Sclerosing Cholangitis Develop a Senescence Phenotype Following Biliary Differentiation.
Nidhi Jalan-Sakrikar, Thiago M De Assuncao, Amaia Navarro-Corcuera, Feda H Hamdan, Lorena Loarca, Brian D Juran

Hepatol Commun· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to 'An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs' [J Hepatol 2021;75(3):572-581].
Heather J Cordell, James J Fryett, Kazuko Ueno, Rebecca Darlay, Yoshihiro Aiba, Brian D Juran

J Hepatol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs.
Heather J Cordell, James J Fryett, Kazuko Ueno, Rebecca Darlay, Yoshihiro Aiba, Brian D Juran

J Hepatol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A scalable workflow to characterize the human exposome.
Xin Hu, Douglas I Walker, Yongliang Liang, Matthew Ryan Smith, Michael L Orr, Brian D Juran

Nat Commun· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The PSC scientific community resource: an asset for multi-omics interrogation of primary sclerosing cholangitis.
Ahmad Hassan Ali, Brian D Juran, Erik M Schlicht, Jackie K Bianchi, Bryan M McCauley

BMC Gastroenterol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bile Acid Profiles in Primary Sclerosing Cholangitis and Their Ability to Predict Hepatic Decompensation.
Omar Y Mousa, Brian D Juran, Bryan M McCauley, Mette N Vesterhus, Trine Folseraas

Hepatology· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of circulating cell-free DNA in cholestatic liver disease using liver-specific methylation markers.
Sohan Punia, Brian D Juran, Ahmad H Ali, Erik M Schlicht, Raymond M Moore

BMC Gastroenterol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-wide resolution peripheral blood methylome profiling reveals signatures for cholestatic liver disease.
Raymond M Moore, Zhifu Sun, Brian D Juran, Konstantinos N Lazaridis

Epigenomics· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-cell mass cytometry on peripheral blood identifies immune cell subsets associated with primary biliary cholangitis.
Jin Sung Jang, Brian D Juran, Kevin Y Cunningham, Vinod K Gupta, Young Min Son

Sci Rep· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary Sclerosing Cholangitis Risk Estimate Tool (PREsTo) Predicts Outcomes of the Disease: A Derivation and Validation Study Using Machine Learning.
John E Eaton, Mette Vesterhus, Bryan M McCauley, Elizabeth J Atkinson, Erik M Schlicht, Brian D Juran

Hepatology· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Studying the Exposome to Understand the Environmental Determinants of Complex Liver Diseases.
Angela C Cheung, Douglas I Walker, Brian D Juran, Gary W Miller, Konstantinos N Lazaridis

Hepatology· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis.
Rudi Alberts, Elisabeth M G de Vries, Elizabeth C Goode, Xiaojun Jiang, Fotis Sampaziotis, Brian D Juran

Gut· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
External validation of the United Kingdom-primary biliary cholangitis risk scores of patients with primary biliary cholangitis treated with ursodeoxycholic acid.
Angela C Cheung, Aliya F Gulamhusein, Brian D Juran, Erik M Schlicht, Bryan M McCauley

Hepatol Commun· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Variations in primary sclerosing cholangitis across the age spectrum.
John E Eaton, Bryan M McCauley, Elizabeth J Atkinson, Brian D Juran, Erik M Schlicht

J Gastroenterol Hepatol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Doublecortin domain containing protein 2 (DCDC2) genetic variants in primary sclerosing cholangitis.
Angela C Cheung, Brian D Juran, Raymond M Moore, Nicholas F LaRusso, Konstantinos N Lazaridis

J Hepatol· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis.
Tobias J Weismüller, Palak J Trivedi, Annika Bergquist, Mohamad Imam, Henrike Lenzen, Brian D Juran

Gastroenterology· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease.
Sun-Gou Ji, Brian D Juran, Sören Mucha, Trine Folseraas, Luke Jostins

Nat Genet· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low incidence of primary biliary cirrhosis (PBC) in the first-degree relatives of PBC probands after 8 years of follow-up.
Aliya F Gulamhusein, Brian D Juran, Elizabeth J Atkinson, Bryan McCauley, Erik Schlicht

Liver Int· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Duration of Inflammatory Bowel Disease Is Associated With Increased Risk of Cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis and IBD.
Aliya F Gulamhusein, John E Eaton, James H Tabibian, Elizabeth J Atkinson, Brian D Juran

Am J Gastroenterol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis